Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,767.60
(
-1.51%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.48
(
1.78%
)
Bitcoin
70,769.13
(
-0.66%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

xavierprivas

Send PM Follow Ignore
Followers 7
Posts 173
Boards Moderated 0
Alias Born 09/14/2009

xavierprivas

Re: biomaven0 post# 207894

Wednesday, 01/11/2017 3:54:50 PM

Wednesday, January 11, 2017 3:54:50 PM

Post# of 257257
GSK filed on June 30 2016 for inter partes review of FGEN Patent 8,609,646 was denied review by the Patent Office today. Explain why FGEN is up while
most biotechs go down

This is just one patent out the six that Glaxo requested a ipr.
(8,466,172; 8,614,204; 8,629,131; 8,604,012; 8,609,646; and 8,604,013)

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now